Sanofi to pay $11.9 mln to resolve U.S. drug kickback probe

Sanofi SA has agreed to pay nearly $11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.

The U.S. Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers' financial support of patient assistance charities.

Sanofi did not admit wrongdoing as part of the settlement.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)